A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation for Elective Awake Fiberoptic Intubation

NCT00383890 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Awake Fiberoptic Intubation

Interventions

DRUG: Dexmedetomidine HCL Injection
DRUG: Placebo

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer